Searchable abstracts of presentations at key conferences in endocrinology

ea0031p364 | Thyroid | SFEBES2013

Clinical performance of fine-needle aspiration biopsy of thyroid nodules in a tertiary referral centre

Glynn Nigel , Hannon Mark , Lewis Sarah , Hillary Patrick , Hill Arnold D K , Keeling Frank , Morrin Martina , McHenry Claire , Smith Diarmuid , Thompson Chris , Leader Mary , Agha Amar

Fine-needle aspiration biopsy (FNAB) is the tool of choice for evaluating thyroid nodules but there is a significant percentage of insufficient or indeterminate aspirates and falsely reassuring results have been reported in up to 6% of cases.We aimed to examine our experience with FNAB among a large cohort of unselected patients with thyroid nodules.239 consecutive patients (211 women) underwent FNA of a thyroid nodule between July...

ea0063p789 | Thyroid 2 | ECE2019

Is repeat fine needle aspiration required in thyroid nodules with initial benign cytology?

Zia-Ul-Hussnain Hafiz Muhammad , Quinn Mark , Dolan Emma , Sherlock Mark , Thompson Chris , Smith Diarmuid , O'Neill James Paul , Leader Mary , Barrett Helen , Hill Arnold , Morrin Martina , Ryan Cliona , Agha Amar

Background: Fine needle aspiration (FNA) is the preferred method for assessing thyroid nodules but concern remains about false negative results. The primary aim of this study was to investigate the malignancy rate in nodules which were initially classified as benign (BTA classification Thy 2). The secondary aim was to look at the distribution of different cytological categories in a large cohort of patients.Methods: We retrospectively examined 719 nodule...

ea0037ep885 | Thyroid cancer | ECE2015

The utility of basal serum thyroglobulin measurement, using a highly sensitive immunoassay, in the follow up of patients treated for differentiated thyroid cancer

Glynn Nigel , Hannon Anne Marie , Schneekloth Lauren , De Buitleir Ciara , Morrin Martina , Keeling Frank , Faul Clare , Leader Mary , Hill Arnold D K , Tormey William , Smith Diarmuid , Thompson Chris J , Agha Amar

Introduction: TSH-stimulated serum thyroglobulin (Tg) is used as a sensitive marker for the detection of early recurrence or residual disease following treatment for differentiated thyroid cancer (DTC). However, stimulated Tg, using TSH or thyroid hormone withdrawal, is either costly or cumbersome for patients.Aim: To compare the performance of basal T4 suppressed, with stimulated Tg measurement, in the follow up of patients treated for DTC.</...